Ye Keng, Lin Kongwen, Wu Chengkun, Zou Zhenhuan, Zhu Yang, Xu Yanfang
Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian, China.
Research Center for Metabolic Chronic Kidney Disease, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian, China.
J Nanobiotechnology. 2025 Apr 27;23(1):320. doi: 10.1186/s12951-025-03392-0.
Acute kidney injury (AKI), characterized by a rapid decline in renal function, is associated with impaired mitochondrial function and excessive reactive oxygen species (ROS). Therefore, the exploration of ROS scavengers provides promising new opportunities for the prevention and treatment of AKI by mitigating oxidative stress. Here, we construct an ultrasmall platinum single-atom enzyme (Pt/SAE) with multiple antioxidant enzyme activities to protect against acute kidney ischemia-reperfusion (I/R) injury. Pt/SAE not only mimics superoxide dismutase and catalase activities to convert superoxide anion into water and oxygen, but also exhibits impressive hydroxyl radical scavenging capacity, thereby reducing pro-inflammatory macrophage levels and preventing inflammation. Furthermore, Pt/SAE reduces the accumulation of Z-form DNA, which excessively accumulates following I/R damage, thus decreasing its interaction with Z-DNA binding protein 1, consequently preventing the progression of PANoptosis following I/R stress. Additionally, the downregulation of ROS levels induced by Pt/SAE suppresses lipid peroxidation, which in return preventing the progression of ferroptosis following I/R. Both in vitro and in vivo experiments confirm that Pt/SAE effectively mitigates inflammatory cell infiltration and promotes a shift in macrophage polarization from the M1-like to M2-like subtype. This study provides promising information for the development of novel SAEs as a viable treatment method for AKI.
急性肾损伤(AKI)以肾功能迅速下降为特征,与线粒体功能受损和活性氧(ROS)过量有关。因此,探索ROS清除剂为通过减轻氧化应激来预防和治疗AKI提供了有前景的新机会。在此,我们构建了一种具有多种抗氧化酶活性的超小铂单原子酶(Pt/SAE),以保护免受急性肾缺血再灌注(I/R)损伤。Pt/SAE不仅模拟超氧化物歧化酶和过氧化氢酶的活性,将超氧阴离子转化为水和氧气,还表现出令人印象深刻的羟基自由基清除能力,从而降低促炎性巨噬细胞水平并预防炎症。此外,Pt/SAE减少了Z型DNA的积累,Z型DNA在I/R损伤后会过度积累,从而减少其与Z-DNA结合蛋白1的相互作用,进而防止I/R应激后PANoptosis的进展。此外,Pt/SAE诱导的ROS水平下调抑制了脂质过氧化,这反过来又防止了I/R后铁死亡的进展。体外和体内实验均证实,Pt/SAE有效地减轻了炎性细胞浸润,并促进巨噬细胞极化从M1样亚型向M2样亚型转变。本研究为开发新型单原子酶作为AKI的可行治疗方法提供了有前景的信息。
Angew Chem Int Ed Engl. 2025-1-27
Adv Sci (Weinh). 2024-12
Adv Sci (Weinh). 2024-5